• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS A1C-3; ASSAY, GLYCOSYLATED HEMOGLOBIN

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS A1C-3; ASSAY, GLYCOSYLATED HEMOGLOBIN Back to Search Results
Model Number HBA1C TQ G3
Device Problem High Test Results (2457)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 03/04/2022
Event Type  malfunction  
Event Description
The initial reporter questioned high results for 2 samples from 1 patient tested for a1c-3 on a cobas 8000 c 502 module.On approximately (b)(6) 2022 the result from the c502 module was 31.8%.This result was reported outside of the laboratory where it was considered to be not believable.This sample was repeated by an unspecified chromatography method and the result was 17.8%.This result was believed to be correct.On (b)(6) 2022 a 2nd sample was obtained and the result from the c502 module was 28.7%.Sometime during the week of (b)(6) 2022 another sample was obtained from the patient and the result from the c502 module was 17.1% which corresponds to the result from the chromatography method.On (b)(6) 2022 the customer repeated another sample from the patient on the c502 module and the result was 16.8% which corresponds to the result from the chromatography method.The c502 module serial number was (b)(4).
 
Manufacturer Narrative
No further information or data was provided by the customer.Sample material was requested for investigation but was no longer available to send.From the information provided, the cause of the event could not be determined.The investigation did not identify a product problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
A1C-3
Type of Device
ASSAY, GLYCOSYLATED HEMOGLOBIN
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
michael leslie
9115 hague road
na
indianapolis, IN 46250
3175214343
MDR Report Key13975880
MDR Text Key289735392
Report Number1823260-2022-00928
Device Sequence Number1
Product Code LCP
UDI-Device Identifier04015630926275
UDI-Public04015630926275
Combination Product (y/n)N
Reporter Country CodeGM
PMA/PMN Number
K102914
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 04/01/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/01/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberHBA1C TQ G3
Device Catalogue Number05336163190
Device Lot NumberASKU
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received03/11/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
AMOXICILLIN/CLAVULANIC ACID (AMOXYCLAV); CARVEDILOL; CLEXANE; FUROSEMIDE; INSULIN; RAMIPRIL
-
-